Potential of Electrical Neuromodulation for Inflammatory Bowel Disease
Abstract
Inflammatory bowel disease (IBD) is a common chronic inflammatory disease of the digestive tract that is often debilitating. It affects patients’ quality of life and imposes a financial burden. Despite advances in treatment with medications such as biologics, a large proportion of patients do not respond to medical therapy or develop adverse events. Therefore, alternative treatment options such as electrical neuromodulation are currently being investigated. Electrical neuromodulation, also called bioelectronic medicine, is emerging as a potential new treatment for IBD. Over the past decade, advancements have been made in electrical neuromodulation. A number of electrical neuromodulation methods, such as vagus nerve stimulation, sacral nerve stimulation, and tibial nerve stimulation, have been tested to treat IBD. A series of animal and clinical trials have been performed to evaluate efficacy with promising results. Although the exact underlying mechanisms of action for electrical neuromodulation remain to be explored, this modality is promising. Further randomized controlled trials and basic experiments are needed to investigate efficacy and clarify intrinsic mechanisms.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 29, 2019
- Source ID
- 10.1093/ibd/izz289
Entities
People
- Florin Selaru
- Hong Shen
- Jiafei Cheng
- Jiande D Z Chen
- Reezwana Chowdhury
- Tsion Abdi
Organizations
- Defense Advanced Research Projects Agency
- Johns Hopkins University
- Naval Information Warfare Center Pacific